Structure Therapeutics Inc.
GPCR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$122,526 | -$89,620 | -$51,321 | -$38,049 |
| Dep. & Amort. | $992 | $295 | $277 | $72 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $18,794 | $8,191 | $2,514 | $1,487 |
| Change in WC | $2,964 | $6,966 | $2,968 | $4,062 |
| Other Non-Cash | -$16,860 | -$5,320 | -$558 | $268 |
| Operating Cash Flow | -$116,636 | -$79,488 | -$46,120 | -$32,160 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,290 | -$2,167 | -$155 | -$1,206 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$702,519 | -$416,993 | -$123,453 | -$4,212 |
| Inv. Sales/Matur. | $344,900 | $151,050 | $61,500 | $23,277 |
| Other Inv. Act. | $0 | -$231 | $0 | $0 |
| Investing Cash Flow | -$358,909 | -$268,342 | -$62,108 | $17,859 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $514,573 | $472,296 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $690 | -$20,765 | $29,014 | $103,254 |
| Financing Cash Flow | $515,263 | $451,531 | $29,014 | $103,254 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $39,718 | $103,701 | -$79,214 | $88,953 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $129,792 | $26,091 | $105,305 | $16,352 |
| End Cash | $169,510 | $129,792 | $26,091 | $105,305 |
| Free Cash Flow | -$117,926 | -$81,655 | -$46,275 | -$33,366 |